Cargando…
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma
Efficacious therapeutic approaches are urgently needed to improve outcomes in patients with oesophageal adenocarcinoma (OAC). However, oncogenic drivers amenable to targeted therapy are limited and their functional characterisation is essential. Among few targeted therapies available, anti‐human epi...
Autores principales: | Gotovac, Jovana R, Liu, David SH, Yates, Michael J, Milne, Julia V, Macpherson, Arthi A, Simpson, Kaylene J, Eslick, Guy D, Mitchell, Catherine, Duong, Cuong P, Phillips, Wayne A, Clemons, Nicholas J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693356/ https://www.ncbi.nlm.nih.gov/pubmed/32737994 http://dx.doi.org/10.1002/path.5528 |
Ejemplares similares
-
ASO Author Reflections: Are Tumor-Infiltrating Neutrophils Drivers of Metastatic Disease in Esophageal Cancer Patients Treated with Neoadjuvant Therapy?
por: Cabalag, Carlos S., et al.
Publicado: (2022) -
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
por: Fisher, Oliver M, et al.
Publicado: (2017) -
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s Esophagus
por: Gotovac, Jovana R., et al.
Publicado: (2021) -
Inhibiting system x(C)(−) and glutathione biosynthesis – a potential Achilles' heel in mutant-p53 cancers
por: Clemons, Nicholas J., et al.
Publicado: (2017) -
The Macronova in GRB 050709 and the GRB-macronova connection
por: Jin, Zhi-Ping, et al.
Publicado: (2016)